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Abstract
In rhesus macaques (RMs), experimental depletion of CD4+ T-cells prior to SIV infection results in higher viremia and
emergence of CD4-independent SIV-envelopes. In this study we used the rhesus recombinant anti-CD4 antibody CD4R1 to
deplete RM CD4+ T-cells prior to SIVmac251 infection and investigate the sources of the increased viral burden and the
lifespan of productively infected cells. CD4-depleted animals showed (i) set-point viral load two-logs higher than controls;
(ii) macrophages constituting 80% of all SIV vRNA+ cells in lymph node and mucosal tissues; (iii) substantial expansion of
pro-inflammatory monocytes; (iv) aberrant activation and infection of microglial cells; and (v) lifespan of productively
infected cells significantly longer in comparison to controls, but markedly shorter than previously estimated for
macrophages. The net effect of CD4+ T-cell depletion is an inability to control SIV replication and a shift in the tropism of
infected cells to macrophages, microglia, and, potentially, other CD4-low cells which all appear to have a shortened in vivo
lifespan. We believe these findings have important implications for HIV eradication studies.
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Introduction
The interaction between HIV and CD4+ T-cells is complex,
and may result in contrasting effects with respect to virus
replication. On the one hand, CD4+ T-cells have a beneficial
role as mediators of antiviral immune responses, both directly
and by providing help for HIV-specific CD8+ T-cells and B cells
[1–4]. On the other hand, CD4+ T-cells are key targets for
infection and sustain virus replication [5,6]. To better under-
stand the relationship between CD4+ T-cell availability and HIV
replication, we recently conducted a CD4+ T-cell depletion study
in rhesus macaques (RMs) prior to SIV infection [7]. This
previous study showed that antibody-mediated depletion of
CD4+ T-cells was associated with increased virus replication and
rapid disease progression [7]. Furthermore, using in vitro
systems we demonstrated the emergence of CD4-independent
SIV envelopes capable of mediating entry into cells expressing
CCR5 without CD4. The absence of antibodies targeting
conserved CD4-inducible epitopes has been proposed as one of
the mechanisms allowing CD4-independent SIV to emerge in
CD4-depleted RMs [8]. Of note, in that study one RM with the
least effective CD4+ T-cell depletion showed the lowest viremia
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and survived throughout the entire study, suggesting that
intermediate levels of CD4+ T-cells may be the ideal balance
between the beneficial and harmful contribution of CD4+ T-cells
to disease progression. This previous study raised some critical
questions, including: (i) is partial depletion of CD4+ T-cells
beneficial? (ii) What cells are the main sources of virus
replication in the absence of CD4+ T-cells, and where are they
located? (iii) What is the in vivo lifespan of these productively
infected cells? And finally, (iv) can we identify correlates of the
high viremia associated with CD4 depletion?
To answer these questions, we designed a new study where we
used a concentration of the CD4 depleting antibody CD4R1
which generated variable levels of CD4+ T-cell depletion allowing
us to test how CD4+ T-cell availability impacts SIV infection.
Furthermore, we performed an extensive combined immunohis-
tochemistry (IHC) and in situ hybridization (ISH) analysis on
colon, jejunal and brain tissues collected at necropsy from the
eight SIV-infected RMs - four CD4-depleted and four controls -
included in Ortiz A.M et al [7]. In contrast to our current study,
these animals were not ART-treated when euthanized. As such,
they represent the ideal samples to investigate the presence and
the phenotype of productively infected cells. Of note, both the
present and the former studies were performed at the same
facility, using the same animal species, virus, route and dose of
infection.
We found that depletion of RM CD4+ T-cells prior to SIV
infection is associated with dramatic changes in the course of
disease, including post-peak viral load two-logs higher than
undepleted controls, expansion of pro-inflammatory monocytes,
and massive activation and infection of macrophages and
microglia that appear to be the predominant population of
productively infected cells. Finally, our analysis of the slope of
viremia decline after initiation of antiretroviral therapy (ART)
suggests that, in the absence of CD4+ T-cells and in the presence
of high levels of activation, the lifespan of these virus targets is
significantly longer than controls, but markedly shorter in
comparison to those previously estimated for macrophages.
Results
Experimental design and extent of CD4+ T-cell depletion
induced by CD4R1
CD4+ T-cells were depleted in eight RMs using a single
administration of CD4R1 antibody at 50 mg/kg, as recommended
by the ‘‘NIH Nonhuman Primate Reagent Resource’’ protocol
(Figure 1a). Of note, this regimen generated variable levels of
CD4+ T-cell depletion in our pilot studies. Four untreated animals
were included as controls. All 12 RMs were infected with
SIVmac251 (i.v. 3,000 TCID50) six weeks post CD4R1 treatment,
in order to avoid the possible confounding effect of direct antiviral
activity of the CD4R1 antibody. At day-52 post-infection (p.i.) all
animals were treated with a three-drugs antiretroviral regimen
(PMPA, FTC, raltegravir). Blood, bone marrow aspirate (BM),
lymph nodes (LN) and rectal biopsies (RB) were collected
longitudinally and at necropsy (Figure 1a).
The efficacy of CD4+T-cell depletion was determined in blood and
tissues by flow cytometry. Figure 1 shows the longitudinal levels
(mean6S.E) of the circulating CD4+T-cells expressed as the absolute
number (b) or fraction of CD3+T-cells (c). Treatment with 50 mg/kg
CD4R1 resulted in a severe depletion in three RMs (orange), but an
intermediate depletion in the remaining five treated animals (blue). Of
note, there was no association between the extent of CD4+ T-cell
depletion and the age, sex, and weight of the animals. Representative
flow plots of the percentage of CD4+ T-cells pre- and post-depletion
are shown in Figure 1d for a severely (top) and an intermediately
(bottom) depleted RM. Severe depletion was characterized by a nadir
CD4+ T-cell frequency of 3.1860.356% (93.5% depletion from
baseline), and CD4+ T-cell counts of 25.6466.877 cells/mL (Figur-
e 1b,c). Intermediately-depleted animals had a nadir CD4+ T-cell
frequency of 18.663.021% (57% depletion from baseline) and CD4+
T-cell counts of 181.2658.98 cells/mL. In both severely- and
intermediately-depleted RMs, the percentage and absolute count of
CD4+ T-cells were significantly lower (P,0.01) than controls at all
experimental points post-depletion (D-35, D-11, D0; Figure 1b,c).
The samegradient ofCD4+T-cell depletionwas confirmed inBMand
LN tissues (Figure 1e). Sincewe used an anti-CD4 antibody clone for
immunophenotyping that is not cross-blocked by CD4R1, and
additionally found a significant reduction in the fraction of CD3+ T-
cells and no selective increase in the fraction of CD3+CD42CD82T-
cells, we are confident that the loss of CD4+T-cells observed following
CD4R1 administration is indeed a true depletion of these cells, rather
than amasking.As expected based onprevious studies [7], depletion of
CD4+T-cells wasminimal atmucosal sites. In severely-depletedRMs,
depletion of CD4+ T-cells induced high levels of proliferation, with in
average 72% of the remaining CD4+ T-cells expressing Ki-67 at D0
(Figure 1f). Although we cannot exclude the contribution of other
mechanisms, including reactivation of latent infections, we interpreted
this high proliferation as an attempt of the immune system to
reconstitute the depleted CD4+ T-cell compartment.
In summary, the variable efficacy of CD4+ T-cell depletion
achieved in this study allowed us to study SIV viral dynamics and
disease progression in RMs with normal, low or extremely low
levels of circulating and tissue resident CD4+ T-cells, therefore
representing an ideal model to address how CD4+ T-cells impact
SIV infection.
Lack of post-peak viral decline in CD4-depleted SIV-
infected RMs
Six weeks post CD4R1 administration all twelve RMs were
infected with SIVmac251 (i.v. 3,000 TCID50). Peak viral load (day
10 p.i.) was similar between CD4-depleted and control RMs
(Figure 2a,b). However, whereas control animals showed a rapid
Author Summary
CD4+ T-cells are both mediators of antiviral immune
response and critical targets for HIV replication. We have
previously shown that experimental depletion of CD4+ T-
cells prior to SIV infection in rhesus macaques results in
higher viremia and the emergence of CD4-independent
SIV-envelopes. The findings reported in this new study of
CD4 depletion address key unanswered questions about
the phenotype, location, and lifespan of the sources of the
increased viral replication in the absence of CD4+ T-cells.
Altogether, our new data indicate that depletion of CD4+
T-cells prior to SIV infection results in activation of
monocyte and massive infection of tissue-resident macro-
phages, which appear to be the predominant population
of productively infected cells. Furthermore, our analysis of
the slope of viremia decline after initiation of antiretroviral
therapy suggests that the lifespan of these virus targets is
markedly shorter than those previously estimated for
macrophages. In summary, in the context of CD4+ T-cell
depletion macrophages can be highly infectable, exhibit
rapid turnover, and short in vivo lifespan. These finding
raises a suggestive hypothesis that eradication of HIV from
this reservoir could be enhanced by therapeutics able to
modulate monocyte/macrophage turnover.
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drop in viral load after the peak, CD4-depleted animals
maintained viremia close to peak levels and ,2-logs higher than
controls in later infection. This difference in viral load was
statistically significant (P,0.001) at each experimental point
between day 21 and day 52 p.i. (Figure 2a,b). Intermediately-
depleted animals exhibited viral kinetics remarkably similar to
those of severely-depleted animals (Figure 2b). Furthermore,
following SIV infection the absolute numbers of CD4+ (a),
CD4+Ki-67+ (b) or CD4+CCR5+ (c) T-cells were comparable in
intermediately-depleted RMs when compared to severely-depleted
animals, and significantly lower than those found in controls at all
the experimental points (Figure S1). Since severely- and
intermediately-depleted RMs had comparable viremia and num-
bers of activated/proliferating T-cells, for the remaining of the
study all eight treated animals were grouped together and defined
as CD4-depleted RMs.
These results show that a partial depletion of CD4+ T-cells is
sufficient for the establishment of an infection phenotype of
persistently high viremia. Furthermore, the presence of a 2-log
higher viremia together with a dramatic loss of CD4+ T-cells
suggests a different source of viral burden in CD4-depleted animals.
Expansion of activated monocytes in CD4-depleted SIV-
infected RMs
Increased activation and turnover of monocytes predict
progression to AIDS in SIV-infected RMs even better than
CD4+ T-cell number [9–11]. Hence, we quantified the levels and
Ki-67 expression of the monocyte subsets in CD4-depleted and
control RMs. Monocytes were defined as classical
(CD14+CD162), pro-inflammatory (CD14+CD16+), and non-
classical (CD142CD16+) based on the expression of CD14 and/
or CD16 (Figure 3a). In the control animals, stable levels of all
monocyte subsets at day 52 p.i. followed their initial expansion.
However, classical and pro-inflammatory monocytes in CD4-
depleted RMs continued to increase, with numbers of
CD14+CD16+ monocytes significantly higher than those of
controls at days 28 (P = 0.0283) and 52 (P= 0.0283) p.i.
Figure 1. Study design and extent of CD4+ T-cell depletion induced by CD4R1. (a) Time line of the study indicating the days in which
CD4R1 was administered, SIVmac251 infection performed, and ART initiated, as well as the experimental points at which blood (PB), bone marrow
(BM), lymph nodes (LN) and rectal biopsies were collected. (b,c) Longitudinal levels (mean6S.E) of the circulating CD4+ T-cells expressed as absolute
number (b) or fraction (c) of CD3+ T-cells in severely depleted (orange square; n = 3), intermediately depleted (blue diamond; n = 5) or undepleted
control (black circle; n = 4) RMs. In both severely- and intermediately-depleted RMs, the percentage and absolute count of CD4+ T-cells were
significantly lower (P,0.01) than controls at all experimental points post-depletion. (d) Representative flow plots showing the fraction of CD4+ T-cells
pre- and post-depletion (day 211) in one severely (top) and one intermediately (bottom) depleted RMs. (e) Levels of CD4+ T-cells expressed as
fraction of CD3+ T-cells in PB, BM and LN immediately before SIV infection (day 0) in severely depleted (S; n = 3), intermediately depleted (I; n = 5) or
control (C; n = 4) RMs. In both severely- and intermediately-depleted RMs, the percentages of CD4+ T-cells were significantly lower (P,0.01) than
controls. (f) Longitudinal levels (mean6S.E) of the fraction of circulating CD4+ T-cells expressed Ki-67 in severely depleted (n = 3), intermediately
depleted (n = 5) or control RMs (n = 4). The gray box in the graphs of panels b, c, f indicates the post-depletion, pre-infection window. *P,0.01.
doi:10.1371/journal.ppat.1004467.g001
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(Figure 3b). Furthermore, and consistent with an activated/pro-
inflammatory status and an increased output from bone marrow,
the number of CD14+CD16+ monocytes expressing Ki-67+ in
CD4-depleted RMs was significantly higher as compared to
controls at days 28 (P= 0.0162) and 52 (P= 0.0485) p.i.
(Figure 3b). At day 52 p.i. CD4-depleted RMs also have a
higher number of proliferating CD14+CD162 and CD142CD16+
monocytes than controls, although the difference was not
statistically significant (Figure 3b). In CD4-depleted RMs plasma
levels of soluble CD163 (sCD163), a marker of monocyte
activation associated with rapid disease progression [9,12,13],
were significantly higher than in controls at day 28 (p= 0.016) and
day 52 (p = 0.048) p.i. (Figure 3c). Of note, at day 52 p.i., levels
of sCD163 strongly correlated with the numbers of total
(r = 0.7483, P = 0.0070) and Ki-67+ (r = 0.6923, P= 0.0155)
CD14+CD16+ monocytes (Figure 3d), as well as with viremia
(r = 0.8322; P = 0.0013) (Figure S2). Thus, depletion of CD4+ T-
cells prior to SIV infection results in increased number, activation
and turnover of monocytes during early SIV infection. As
indicated in Figure 1a, all 12 SIV-infected RMs were started on
ART at day 52 p.i. The numbers of pro-inflammatory monocytes
(CD14+CD16+; P = 0.0145) and their levels of Ki-67 expression
(P = 0.0189) after 12 days of ART (day 64 p.i) were significantly
decreased as compared to pre-ART (day 52 p.i.) levels, and
become comparable to those found in controls (Figure 3b).
Classical (CD14+CD162) and non-classical (CD142CD16+)
monocyte levels were not significantly affected by ART (Fig-
ure 3b). Levels of sCD163 remained significantly higher in CD4
depleted animals than controls after 12 days of ART (Figure 3c).
Of note, the interpretation of the effects of ART in the
aforementioned parameters, in particular for sCD163, is compli-
cated by the fact that we were able to only treat the animals for a
short period. Indeed, and perhaps as a consequence of the fact that
CD4-depletion resulted in very high virus replication, seven of the
eight depleted RMs had to be euthanized for AIDS-related
reasons briefly after ART initiation (Table S1).
Macrophages are highly infected and constitute the
major contributors to systemic viremia in CD4-depleted
RMs
We next investigated the levels of SIV infection of macrophages
in peripheral lymph node and intestine from CD4-depleted and
control RMs by immunofluorescence staining for cell lineage
markers combined with fluorescence in situ hybridization (F-ISH)
for SIV vRNA. Since monocyte/macrophage express CD4, we
used CD3 to determine the infection frequency of CD4+ T-cells. At
day 42 p.i. SIV vRNA+ cells were more frequent in the LN of CD4-
depleted animals as compared to controls (Figure 4a), consistent
with the ,2-log higher plasma viremia found at the same
experimental point. The vast majority of SIV vRNA+ cells
expressed the T cell marker CD3 in undepleted controls, but
macrophage markers (CD68 and/or CD163) in CD4-depleted
RMs. We then performed the same F-ISH staining on day 42 rectal
biopsies from the RMs included in the current study as well as on
colon and jejunal tissues at necropsy from the four CD4-depleted
animals included in Ortiz A.M et al [7]. In contrast to our current
study, those latter animals were not ART-treated and thus showed
high viremia when euthanized. The same phenomena of increased
levels of total SIV vRNA+ cells and expression of macrophage
markers by infected cells were observed in the intestine of CD4-
depleted (Figure 4b), but not of control RMs. Quantitative image
analysis of LN and intestinal tissues showed that in undepleted
controls more than 80% of SIV vRNA+ cells were CD3+ T-cells,
while in CD4-depleted RMs ,80% of SIV vRNA+ cells were
CD68+ and/or CD163+ macrophages (Figure 4c).
Although the majority of infected cells in CD4-depleted animals
were macrophages, it is possible that infection of these cells was a
result of high viral loads, and they did not contribute substantially to
the total viral load because they produced little virus per infected cell.
In order to determine whether viral production from macrophages
was likely to contribute to the total viral load, we sought to compare
the relative abundance of SIV vRNA in productively infected CD4+
Figure 2. Increased plasma viremia in CD4-depleted SIV-infected RMs. Longitudinal levels (mean6S.E) of viral load, expressed as number of
SIVmac251Gag RNA copies per mL of plasma, in CD4-depleted (orange square; n = 8) vs. undepleted control (black circle; n = 4) RMs (a) as well as in
severely depleted (orange square; n = 3), intermediately depleted (blue diamond; n = 5) or undepleted control (black circle; n = 4) RMs (b). In both
severely- and intermediately-depleted RMs, viral loads were significantly higher than controls from day 21 to day 52 post-infection. *P,0.01.
doi:10.1371/journal.ppat.1004467.g002
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T cells to that of macrophages in four CD4-depleted RMs. We
measured the volumetric sum of the SIV vRNA intensity integration
values in defined productively SIV infected CD3+ and CD68/
CD163+ cells in situ from confocal images collected under identical
laser settings. Using this approach we were able to demonstrate that,
within a particular host, macrophages have similar or even higher
(on average two-fold more) SIV vRNA content per cell than
productively infected CD4+ T-cells (Figure 4d).
Altogether, these data indicate that depletion of CD4+T-cells prior
to SIV infection results in activation ofmonocyte andmassive infection
of tissue-resident macrophages. These infected macrophages have
higher levels of SIV vRNA than infectedCD4+T cells, and, since they
constitute 80% of all infected cells in CD4-depleted animals, they are
most likely the major source of systemic viremia in these animals.
Massive activation and productive infection of microglia
in CD4-depleted RMs
We then investigated if the observed high viremia, monocyte
activation, and infection of macrophages in peripheral tissues were
associated with central nervous system (CNS) virus dissemination
and pathology. First, we investigated the presence of infected cells in
brain sections collected at necropsy from the CD4-depleted and
non-depleted (SIV+ controls) SIV-infected RMs included in our
previous study (in contrast to the current study, these animals were
not treated with antiretroviral drugs at the time of necropsy [7]). For
the SIV negative controls, we used brain sections from historically
SIV-uninfected RMs present at the Tulane National Primate
Research Center (SIV2 controls). In CD4-depleted RMs SIV
vRNA+ cells were found throughout the parenchyma (Figure 5a)
and had a stellate morphology typical of microglia. The high
number of infected cells led us to evaluate, in the same brain
sections, the levels of activation by IHC/IF staining for CD163,
HLA-DR, and proliferating cell nuclear antigen (PCNA, a marker
of perivascular macrophages that has been used as a marker of DNA
repair in macrophages [14]). As shown in the representative images
(b) and in the quantitative analysis (c) of Figure 5, the expression of
CD163 (P= 0.0013; P= 0.0047), HLA-DR (P=0.0571;
P= 0.0571), and PCNA (P=0.0026; P= 0.0121) in cells with
Figure 3. Expansion of activated, pro-inflammatory monocytes in CD4-depleted SIV-infected RMs. (a) Representative flow plots of
different monocyte subsets as defined by CD14 and CD16 expression. Levels of Ki-67 and FMO controls are represented for classical (CD14+CD162), pro-
inflammatory (CD14+CD16+), and non-classical (CD142CD16+) monocytes. (b) Quantification of total and Ki-67+ blood monocyte subsets (cells/ml) in SIV-
infected CD4-depleted (orange square; n =8) and undepleted control (closed circle; n= 4) RMs. In depleted RMs, the number of total and proliferating
CD14+CD16+monocytes was significantly higher than undepleted controls at day 28 and 52 post-infection. (c) In CD4-depleted RMs (orange square; n=8)
plasma levels of soluble CD163 (sCD163) were significantly higher than undepleted controls (closed circle; n = 4) at day 28 and day 52 post-infection, as
well as after 12 days of ART. (d) Plasma level of sCD163 significantly correlates with the numbers of CD14+CD16+ and of CD14+CD16+Ki-67+monocytes in
all SIV-infected RMs (day 52 p.i.; n = 12; Spearman rank correlation tests). The gray box in the graphs of panels b and c indicates the 12 days of ART.
doi:10.1371/journal.ppat.1004467.g003
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location and stellate morphology typical of microglia were
significantly higher in CD4-depleted than SIV-uninfected or SIV-
infected controls. The surprising finding that a significant number of
microglia are activated and productively infected was confirmed by
triple fluorescent labeling for SIV vRNA (red), CD163 (blue) and
the microglia-specific marker IBA-1 [15] (green) (Figure 5d).
Quantification of these stainings showed numbers of SIV vRNA+
IBA-1+ microglia markedly higher in CD4-depleted compared to
non-depleted SIV-infected animals (11.368.4 vs. 0.260.2;
P= 0.0286). Of note, we found a direct correlation between the
number (cells/mm2) of SIV vRNA+ cells and PCNA+ cells in the
eight CD4-depleted animals (r = 0.8289, P= 0.0302).
Collectively, these results indicate that depletion of CD4+ T-
cells in RMs results in massive activation and infection of
microglia.
Short lifespan of productively infected cells in CD4-
depleted, SIV-infected RMs
One way of testing the longevity of infected cells is to block new
rounds of infection with ART and measure the rate of viral decay
(which reflects the death rate of productively infected cells present at
the time of treatment). Thus, if infected macrophages have a longer
survival than infected CD4 T cells, we should expect to see a much
slower decay of virus under therapy in CD4-depleted RMs, where
infected macrophages are the major source of systemic viremia.
To directly estimate the in vivo lifespan of the productively
infected cells, all 12 SIV-infected RMs were started on ART at day
52 p.i. We then measured and modeled the slope of viral load decay
during ART as described in previous studies [16–19]. As described
above, seven of the eight depleted RMs had to be euthanized for
AIDS-related reasons briefly after ART initiation (Table S1). As a
result of this, we were able to perform only three sample collections,
one at ART initiation (day 0) and the other two at day 7 and day 12
on-ART (Figure 6a). Since at day 12 on-ARTwe already lost three
CD4-depleted animals, the lifespan of productively infected cells was
estimated based on viral load changes between day 0 and day 7,
although the same conclusions were reached if we used the smaller
subset of animals alive at day 12. As expected, the viral decay in
control animals was rapid, with an estimated half-life of infected cells
of 0.77560.01 days, which was consistent with previous estimates.
Figure 4. Massive SIV infection of LN and intestinal macrophages in CD4-depleted RMs. (a) Immunofluorescence staining for T cell (CD3;
blue) and macrophage (CD68 and/or CD163; green) lineage markers combined with in situ hybridization for SIV vRNA (red) in the LN isolated at day
42 post-infection from one representative undepleted control (left) and one CD4-depleted RM. The vast majority of SIV vRNA+ cells express CD3 in
undepleted control but express CD68/CD163 in CD4-depleted RM. (b) The same staining is shown for colon (top) and jejunum (bottom) tissues in two
representative CD4-depleted animals. (c) Quantitative image analysis of LN and mucosal tissues showing the fraction of SIV vRNA+ cells that express
CD3 or CD68/CD163 in CD4-depleted (n = 12; the 8 animals in this study plus the 4 in Ortiz et al 2011) or undepleted control RMs (n = 6; two
SIVmac251 infected animals belonging to a different study were added as controls). (d) Relative abundance of SIV vRNA+ in productively infected T
cells and macrophages, determined by measuring the volumetric sum of the SIV vRNA+ intensity integration values in situ from confocal images
collected under identical laser settings, is shown in four CD4-depleted RMs. Macrophages on average have higher per cell SIV vRNA+ content
compared to CD4+ T cells within the same host. Statistical analyses were determined by Mann-Whitney test.
doi:10.1371/journal.ppat.1004467.g004
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The lifespan of productively infected cells was significantly longer in
the CD4-depleted animals (1.3360.108 days, P=0.0238; Fig-
ure 6b), but was considerably shorter than expected for HIV
infected macrophages [20–22]. Thus, in CD4-depleted RMs,
macrophages constitute the main productively infected cell type,
produce the majority of virus, and show a relatively short in vivo
lifespan. Further analysis of cell death in a subset of animals showed a
statistically significant higher number of TUNEL positive cells (the
vast majority of which express CD163) in the brain parenchyma in
CD4-depleted RMs than in controls (p= 0.0439) and CD4-depleted
animals on-ART (p=0.0002) (Figure S3a). The increased cell
death was not Caspase-3 mediated since the number of cells positive
for the active form of Caspase-3 was comparable between SIV-
infected CD4-depleted RMs and controls (Figure S3b).
Discussion
We previously showed that a severe depletion of CD4+ T-cells is
associated with increased viremia, emergence of CD4-independent
viruses and rapid progression to AIDS in SIV-infected RMs [7]. In
this new study we used CD4R1, a rhesus recombinant anti-CD4
depleting antibody, to achieve a gradient of CD4+ T-cells in vivo.
This strategy allowed us to experimentally infect with SIVmac251
RMs with normal, low or very low level of CD4+ T-cells in blood
and lymphoid tissues. The critical questions we aimed to answer in
this study were the following: (i) is partial depletion of CD4+ T-
cells beneficial? (ii) What cells are the main sources of virus
replication in the absence of CD4+ T-cells, and where are they
located? (iii) What is the in vivo lifespan of these productively
infected cells? And (iv) can we identify correlates of the high
viremia associated with CD4 depletion? Answering these questions
may have important implications for our understanding of HIV
pathogenesis and latency.
Viral loads were indistinguishable between CD4-depleted and
control RMs for the first 14 days p.i. However, severely- and
intermediately-depleted RMs maintained viremia ,2-logs higher
than undepleted controls at all subsequent experimental points.
Thus, partial depletion of CD4+ T-cells prior to infection did not
Figure 5. Massive activation and productive infection of microglia in CD4-depleted RMs. (a) ISH showing the levels of SIV vRNA+ cells in
brain from a representative SIV-uninfected control (top), SIV-infected control (middle) and CD4-depleted SIV-infected (bottom) animal. The amount of
SIV vRNA+ cells was markedly higher in CD4-depleted animals than in controls. (b) Immunofluorescence staining for CD163 (left panels), HLA-DR
(middle panels) and proliferating cell nuclear antigen (PCNA; right panels) in the parenchyma of one representative SIV-uninfected control (top), one
SIV-infected control (middle) and one SIV-infected CD4-depleted (bottom) RM. Nuclei are stained in green; markers of interest in red. (c) Quantitative
analyses showing the number of cells per mm2 of tissue that stained positively for the markers of interest. Increased expression of CD163, HLA-DR
and PCNA was found in CD4-depleted animals (orange square; n = 4) when compared to both groups of controls (SIV- open circle, n = 3; SIV+ closed
circle, n = 3). (d) Single and combined staining for IBA-1 (green), CD163 (blue), and SIV-vRNA (red) in the brain of one representative SIV-infected CD4
depleted RM. The box on the right is a magnification of a microglial cell (IBA-1+) that expresses CD163 and is productively infected (SIV vRNA+).
doi:10.1371/journal.ppat.1004467.g005
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result in a more benign course of infection and was sufficient to
generate the higher viremia phenotype. CD4R1 was efficient in
depleting CD4+ T-cells from blood, BM, and LN but not from
mucosal sites. Thus, mucosal CD4+ T-cells may be responsible for
maintaining peak viral loads in depleted RMs similar to that in
controls, before being severely depleted in the first weeks of
infection due to the high levels of SIV replication. Of note, our
data on the level of proliferating cells does not support the
possibility that CD4-depleted RMs have higher numbers of T-cells
that can support viral replication as a result of the high level of
activation/proliferation in the remaining CD4+ T-cells. Thus, in
RMs the association of viremia that is ,2-logs higher with a
profound loss of CD4+ T-cells is consistent with an alternative
critical source of virus replication.
The observed high viremia in the context of very low levels of
CD4+ T-cells prompted us to investigate the susceptibility of
macrophages/myeloid cells to SIV infection. Remarkably, we
showed directly in situ that CD4-depletion induces a significant
shift in the nature of productively infected cells, with 80% of SIV
vRNA+ cells in LN and mucosal tissues being CD3+ T-cells in
undepleted controls but CD68/CD163+ macrophages in CD4-
depleted RMs. It has recently been described that increased
activation and rapid turnover of monocytes, in particular those
with a CD14+CD16+ phenotype, associates with macrophage
destruction in tissues and predicts the tempo of progression to
AIDS in SIV-infected RMs [9–11]. In response to activation,
CD163 is cleaved from the cellular surface of monocytes/
macrophages and is shed as sCD163 [23]. Recently, sCD163
has been indicated as a strong correlate of monocyte activation
and turnover as well as disease progression in SIV-infected RMs
[9]. Consistent with these studies, CD4-depleted RMs, but not
undepleted controls, experienced a substantial increase in the
number of circulating CD14+CD16+ monocytes. Furthermore,
plasma levels of sCD163 were significantly higher in CD4-
depleted than in undepleted control RMs, and directly correlated
with viral load as well as with the numbers of total and
proliferating CD14+CD16+ monocytes. Although in vivo BrdU
labeling studies were not performed, the findings of higher
frequency of Ki-67+ monocytes and sCD163 plasma levels are
consistent with a model in which CD4-depletion prior to SIV
infection results in increased activation/turnover of monocytes.
The key findings we described in CD4-depleted animals - high
viral load, expansion of pro-inflammatory monocyte, increased
level of sCD163, and massive infection of tissue-resident macro-
phages/myeloid cells – are all potential markers of CNS infection
[7,9,13,24–27]. In this study, CD4-depleted animals were
euthanized during ART, thus the analyzed brain tissues did not
represent the ideal samples to investigate the presence of
productively infected cells. To overcome this limit, we stained
brain sections collected in our previous study of CD4+ T-cell
depletion that did not include ART [7]. It is worth mentioning
that both the present and the former studies were performed at the
same facility, using the same species, virus, route and dose of
infection. Furthermore, the high viremia and rapid disease
progression phenotype was remarkably similar between the two
studies. Our combined IHC/ISH approach provided three
surprising results. First, a large fraction of microglial cells from
CD4-depleted animals expressed high levels of activation/prolif-
eration/DNA repair markers, such as CD163, HLA-DR and
PCNA, that were absent or exclusively present in perivascular
macrophages in brain tissue of uninfected RMs and undepleted
SIV-infected RMs. Second, the amount of SIV vRNA+ cells was
remarkably higher in the brain of CD4-depleted RMs when
compared to undepleted SIV-infected controls, thus consistent
with what we found in LN and RB tissues. Third, and uniquely for
the CD4-depleted RMs, SIV vRNA+ cells include not only
perivascular macrophages but also cells with anatomic location,
morphology, and phenotype typical of microglia. Demonstrable in
vivo infection of microglia in SIV-infected RMs, particularly at the
extent found here, is an exceedingly rare event even in the well-
developed models of accelerate SIVE induced by depletion of
CD8+ T-cells or by joint infection with an immune-suppressive
and a neurovirulent SIV-variants [9,15,28].
Based on the paucity of CD4+ T-cells and the infection of
macrophages/myeloid cells, which are typically thought to be
long-lived cells, we hypothesized that in CD4-depleted RMs viral
Figure 6. Viral decay kinetics in CD4-depleted and control RMs. (a) Longitudinal levels (mean6S.E) of viral load, expressed as number of
SIVmac251Gag RNA copies per mL of plasma, in ART-treated CD4-depleted (orange square; n = 6) and undepleted control (closed circle; n = 3) RMs.
Viral load was assessed at ART-initiation (day 0) as well as at day 7 and day 12 on-ART. (b) In vivo lifespan of the predominant population of
productively infected cells was estimated for CD4-depleted and undepleted control RMs based on the viral load changes between day 0 and day 7
(although the same conclusions were reached if we included day 12) showed in (a). Two CD4-depleted RMs were sacrificed before day 7 on-ART (one
at day 3 and one at day 6 on-ART; see Table S1); thus, the graph includes the six CD4-depleted animals for which data were available at day 7 on-ART.
doi:10.1371/journal.ppat.1004467.g006
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load decay during ART would be slower when compared to
undepleted controls. In CD4-depleted RMs the lifespan of the
main productively infected cells was 1.3 days, considerably shorter
than what is generally expected for macrophages [20,21,29].
Two caveats must be considered when discussing this result.
The first is that the decay model assumes that viral load is at
steady-state and ART is equally effective at inhibiting viral
replication in depleted and control animals. The second is related
to a specific limitation of our study. Due to the poor clinical
conditions of CD4-depleted RMs at ART initiation and their
rapid disease progression, we could not sample these animals as
frequently and as long as originally planned. Thus, the estimates of
viral decay rates are based on a few relatively early experimental
time points on-ART. However, given the rapid rate of decay in
both groups, we were able to measure a substantial drop in viral
load over seven days in both cases, and observed a significant
difference in the decay rate of infected cells between control and
CD4-depleted animals. These caveats notwithstanding, we con-
cluded that the bulk of the available data are consistent with the
idea that– in the context of CD4+ T-cell depletion and high levels
of activation/inflammation—macrophages can be highly infect-
able, exhibit rapid turnover, and short in vivo lifespan when
infected. In this regard, our data are consistent with recent findings
indicating that rapid turnover of monocyte/macrophages deter-
mined by in vivo Brdu labeling predicted AIDS progression
better than viral load or lymphocyte activation [9,10,30]. An
alternative interpretation of the short lifespan of productively
infected cells in CD4-depleted RMs is that the few remaining
productively infected CD4+ T-cells produce much more virus
than productively infected macrophages on a per cell basis. Thus
in this scenario, T-cells could still constitute the major source of
virus production measured in the plasma. However, this seems
extremely unlikely because the differences in virus production
would need to be dramatically skewed in favor of productively
infected CD4+ T-cells, considering that they represent only 20%
of all productively infected cells. In fact, when we measured in
situ the relative volumetric abundance of SIV vRNA within
CD3+ T cells and CD68/CD163+ macrophages, we found that
macrophages on average have even higher per cell SIV vRNA
content (,2-fold greater) compared to productively infected
CD4+ T-cells within the same host. With macrophages repre-
senting approximately 80% of all productively infected cells in all
examined tissues, and with higher levels of SIV vRNA per cell in
infected macrophages, it is safe to conclude that macrophages are
the main productively infected cells in CD4-depleted animals. It
is important to note that, due to the short length of ART-
treatment, our data do not exclude the existence of a
subpopulation of SIV-infected, long-lived macrophages. Howev-
er, this would constitute a very small percentage of total viral
production at most, because of the observed rapid viral load seen
in CD4-depleted animals.
In conclusion, our study demonstrates that, in SIV-infected
RMs, the net effect of CD4+ T-cell depletion is the inability to
control SIV replication and a shift in the pattern of infected cells
from CD4+ T-cells to macrophages, microglia, and, potentially,
other CD4-low cells. These findings have important implica-
tions for functional cure and eradication studies as they indicate
that macrophages and microglia can be critical target for virus
infection in the context of a severely compromised immune
system. Furthermore, our finding that HIV-infected macro-
phages can be short-lived if highly activated raises a suggestive
hypothesis that eradication of HIV from this reservoir could
be enhanced by therapeutics able to modulate monocyte/
macrophage turnover.
Materials and Methods
Ethics statement
All animal experimentations were conducted following guide-
lines established by the Animal Welfare Act and the NIH for
housing and care of laboratory animals and performed in
accordance with Institutional regulations after review and
approval by the Institutional Animal Care and Usage Committees
at the Yerkes National Primate Research Center (YNPRC). All
efforts were made to minimize suffering. All the blood and tissue
collections were obtained from RMs housed at the Yerkes
National Primate Research Center, which is accredited by
American Association of Accreditation of Laboratory Animal
Care. RMs are fed standard monkey chow (Jumbo Monkey Diet
5037, Purina Mills, St Louis, MO) twice daily. Consumption is
monitored and adjustments are made as necessary depending on
sex, age, and weight so that animals get enough food with
minimum waste. SIV-infected RMs are singly caged but have
visual, auditory, and olfactory contact with at least one social
partner, permitting the expression of non-contact social behavior.
The YNPRC enrichment plan employs several general categories
of enrichment. Animals have access to more than one category of
enrichment. IACUC proposals include a written scientific
justification for any exclusions from some or all parts of the plan.
Research-related exemptions are reviewed no less than annually.
Clinically justified exemptions are reviewed more frequently by the
attending veterinarian. This study was performed in strict
accordance with the recommendations in the Guide for the Care
and Use of Laboratory Animals of the National Institutes of
Health, a national set of guidelines in the U.S. and also to
international recommendations detailed in the Weatherall Report
(2006). This work received prior approval by the Institutional
Animal Care and Use Committees (IACUC) of Emory University
(IACUC protocol #2000353, entitled ‘‘Homeostasis of CD4+ T
cells in non-human primates’’). Appropriate procedures were
performed to ensure that potential distress, pain, discomfort and/
or injury was limited to that unavoidable in the conduct of the
research plan. The sedative Ketamine (10 mg/kg) and/or Telazol
(4 mg/kg) were applied as necessary for blood and tissue
collections and analgesics were used when determined appropriate
by veterinary medical staff.
Animals, CD4 depletion and antiretroviral therapy
Twelve female RMs were included in this study. Eight of them
were treated with a single administration of the anti-CD4 antibody
CD4R1 at 50 mg/kg (intravenous), as recommended by the ‘‘NIH
Nonhuman Primate Reagent Resource’’ protocol. CD4R1 has
rhesus constant regions and rhesus variable framework sequences.
Only the CDRs (and a few amino acids critical for Ig
conformation) are derived from the original mouse antibody.
Four untreated animals were included as controls. All 12 RMs
were infected with SIVmac251 (i.v. 3,000 TCID50) six weeks post
CD4R1 treatment. At D52 post-infection all animals were treated
once a day with Tenofovir (30 mg/kg; s.c.), Emtricitabine (30 mg/
kg; s.c.) and Raltegravir (100 mg; oral). Furthermore, we used
paraffin embedded tissues, including brain, collected at necropsy
from the eight SIV-infected RMs (four CD4-depleted and four
controls) included in Ortiz A.M et al [7]. All animal experimen-
tations were conducted following guidelines established by the
Animal Welfare Act and the NIH for housing and care of
laboratory animals and performed in accordance with Institutional
regulations after review and approval by the Institutional Animal
Care and Usage Committees at the Yerkes National Primate
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Research Center (YNPRC). All efforts were made to minimize
suffering.
Sample collection and processing
Collections and processing of blood, bone marrow aspirate
(BM), lymph nodes (LN) and rectal (RB) biopsies were performed
longitudinally and at necropsy as previously described [31–34].
Briefly, blood samples have been used for a complete blood count,
and plasma separated by centrifugation within 1 h of phlebotomy.
Peripheral blood mononuclear cells were prepared by density
gradient centrifugation. BM aspirates were performed using an
aspiration kit to remove approximately 1 mL. For rectal biopsies,
an anoscope has been placed a short distance into the rectum and
up to 20 pinch biopsies obtained with biopsy forceps. RB-derived
lymphocytes have been isolated by digestion with 1 mg/ml
collagenase for 2 h at 37uC, and then passed through a 70-mm
cell strainer to remove residual tissue fragments. For lymph node
biopsies, the skin over the axillary or inguinal region have been
clipped and surgically prepared. An incision has been made over
the LN, which has been exposed by blunt dissection and excised
over clamps. Biopsies have been homogenized and passed through
a 70-mm cell strainer to mechanically isolate lymphocytes. All
samples were processed, fixed (1% paraformaldehyde), and
analyzed within 24 hours of collection.
Flow cytometric analysis
Twelve-parameter flow cytometric analysis was performed on
WB, LN, RB and BM derived cells according to standard
procedures using a panel of monoclonal antibodies that we and
others have shown to be cross-reactive with RM [35–37].
Predetermined optimal concentrations were used of the following
antibodies: anti-CD3-Alexa700 (clone SP34-2), anti-CD3-APC-
Cy7 (clone SP34-2), anti-CD4-Pacific Blue (clone OKT4), anti-
CD8-APC-Cy7 (clone SK1), anti-CD95-PE-Cy5 (clone DX2),
anti-CCR5-APC (clone 3A9), anti-Ki-67-Alexa700 (clone B56),
anti-Ki-67-FITC (clone B56), anti-CD14-Pe-Cy7 (clone M5E2),
anti-CD16-BV421 (clone 3G8), anti-CD62L-PE (clone SK11),
anti-CCR7-PE-Cy7 (Clone 3D12) (all from BD Pharmingen); anti-
CD28-ECD (clone CD28.2) (Beckman Coulter); anti-CD8-
Qdot705 (clone 3B5) and Aqua Live/Dead amine dye-AmCyan
(Invitrogen). Intracellular staining for Ki-67 was performed at
room temperature for 30 minutes following permeabilization with
cytofix/cytoperm (BD Bioscience). Flow cytometric acquisition
was performed on an LSRII cytometer driven by the FACS DiVa
software. Analysis of the acquired data was performed using
FlowJo software (TreeStar) and graphs were prepared using Prism
version 6.0 (GraphPad).
Determination of viral load RNA
Quantitative real-time RT-PCR assay to determine SIV viral
load was performed as previously described [38].
SIV vRNA in situ hybridization, immunohistochemical,
confocal microscopy and quantitative image analysis of
brain tissue
To detect viral RNA in the tissues, in situ hybridization for SIV
was performed using riboprobes as described previously [39].
Briefly, 7 mm-thick formalin-fixed, paraffin-embedded tissue
sections were de-paraffinazed through a graded series of xylenes
and ethanol and rehydrated in water threated with diethylpyr-
ocarbonate (DEPC; Sigma; Aldrich, St. Louis, MO) before
antigen retrieval by boiling in a microwave for 20 minutes in
citrate buffer pH 6. The tissue sections were blocked with
hybridization buffer containing 50% formamide with denatured
herring sperm DNA and yeast tRNA at 10 mg/ml each in a
humidified chamber at 45uC for 1 hr. Hybridization was
performed with SIV-digoxigenin-labeled anti-sense riboprobes
(Lofstrand Labs Ltd; Gaithersburg, MD) that were applied to the
tissue sections at 10 ng/slide in hybridization buffer and
incubated overnight at 45uC. After hybridization, slides were
washed sequentially with 26SSC, 16SSC, and 0.16SSC. The
slides were incubated in TBS (tris buffer saline, 10 mM, pH 7.4)
and followed with blocking solution for 1 h. Alkaline phospha-
tase-conjugated sheep anti-digoxigenin antibody diluted at 1:200
(Roche; Penzberg, Germany) was used to detect hybridized
digoxigenin-labeled probes. Either Dako Liquid Permanent Red
or NBT/BICP substrate-chromogens system (Dako, Inc. Carpin-
teria, CA) were prepared according to manufacturer’s instruc-
tions and added to the tissue for 20 min at room temp to develop
the reaction. Controls included matched positive and negative
tissues hybridized with digoxigenin-labeled sense RNA-labeled
probes and processed in parallel.
Formalin-fixed, paraffin-embedded tissue sections (5–6 mm
thick) were examined by immunohistochemical staining using
the following primary antibodies: Anti CD163 (clone EDHu-1,
AbD Serotec), HLA-DR (clone LN3, eBioscience), and PCNA
(clone PC10, DAKO). Reactivity to primary antibodies was
detected using the MACH3 alkaline phosphatase polymer
detection kit from Biocare Medical (Concord, CA) with either
NBT/BCIP substrate system for light microscopy or Permanent
red for fluorescent microscopy both from Dako (Carpinteria, CA)
after which sections were counterstained using YO-PRO nuclear
stain (Life Technologies, Grand Island, NY). As controls,
duplicate sections were processed in the absence of primary
antibodies.
Triple label confocal microscopy was performed to co-localize
SIV-RNA with cell type specific markers to determine the
immunophenotype of infected cells as described previously [39].
Immunofluorescent labeling for microglia (rabbit polyclonal
against IBA-1, Wako) and macrophages (Mouse IgG1 monoclonal
to CD163, novocastra) was performed after ISH as previously
described [15]. After incubation with the primary antibodies and
subsequent washes, the appropriate species-specific secondary
antibodies were applied; AlexaFluor 488 (green) conjugated goat-
anti-rabbit (Invitrogen, Carlsbad, California) and AlexaFluor 647
(far-red, shown in blue) conjugated goat-anti-mouse IgG1
(Invitrogen, Carlsbad, California), respectively. To image the
sections a Leica TCS SP2 confocal microscope equipped with 3
lasers (Leica Microsystems, Exton, PA) with a resolution of
5126512 pixels was used. The confocal imaging was performed
using sequential mode to separately capture the fluorescence from
the different fluorochromes. Volocity Software (v 5.5, Perkin-
Elmer) was used to render the images from the Leica z stacks.
Adobe Photoshop software (Version CS6; Adobe Systems) was
used to assemble the images.
Quantitation of positive cells was performed manually for the
SIV-RNA detection with NBT/BICP (purple-black color) by
counting positive cells per field in 10 randomly selected fields
encompassing a minimum of 120 mm2. The numbers of infected
cells are expressed as cells per mm2. Quantitation of cells labeled
for the cell type specific antigens was performed on immunola-
beled slides using Inform v2 1.2 software after capturing 10
randomly selected fields encompassing a minimum of 30 mm2
with a CRI-multispectral camera using Nuance software v 3.0.2
(Perking-Elmer). The positive cell numbers are express as cells in
mm2. Prism v5 software (GraphPad software) was used to present
the data in a graphic form.
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SIV vRNA in situ hybridization, immunohistochemical
analysis and quantitative image analysis in lymph node
and intestinal tissues
Fluorescent in situ hybridization (F-ISH) was performed using
our newly designed SIV riboprobes as previously published [7]. In
brief, 5-mm tissue sections were mounted on Superfrost Plus
Microscope Slides (Fisher Scientific), heated at 60uC for 1 h,
dewaxed in xylenes and graded ethanols, and rehydrated in
double-distilled H2O. Heat-induced epitope retrieval was per-
formed by placing slides in in 10 mM Citrate (pH 6.0) containing
0.05% Tween-20 or Pretreatment-2 buffer (Advanced Cell
Diagnostics, Inc.) at 100uC for 5 min followed by immediate
immersion into HyPure molecular biology–grade H2O (Hyclone;
Thermo Scientific) at room temperature. The slides were then
incubated for 5 minutes at 37uC in a Tris-buffered solution
containing 2 mM CaCI2 and proteinase K (1.25 mg/ml) then
washed in HyPure molecular biology–grade H2O (Hyclone;
Thermo Scientific), acetylated (0.25% acetic anhydride) for
20 minutes, and placed in 0.1 M triethanolamine (pH 8.0) until
hybridization. Sections were then covered with hybridization
solution (50% deionized formamide, 10% dextran sulfate, 0.6 M
NaCI, 0.4 mg/ml yeast RNA (Ambion Inc.), and 16 Denhardt
medium in 20 mM HEPES buffer (pH 7.2) with 1 mM EDTA)
containing 100–400 ng/ml pooled SIV riboprobes and hybridized
for 18 hours at 48uC. After hybridization, slides were washed in
56 SSC (16 SSC=0.15 M NaCL+0.015 M Sodium Citrate) at
42uC for 20 minutes, 26 SSC in 50% formamide at 50uC for
20 minutes, and 16RNA wash buffer (RWB: 0.1M TRIS-HCL
PH 7.5, 0.4M NaCL, 0.05M EDTA PH 8.6) at 37uC with
ribonuclease A (25 mg/ml) and T1 (25 U/ml) for 30 minutes.
After washing in RWB buffer, 26 SSC, and 0.16 SSC at 37uC
for 15 minutes each, sections were transferred to 16 Tris-
buffered saline (TBS; Boston BioProducts) containing 0.05%
Tween-20 (TBS-Tw). Tissues were blocked in TBS-Tw contain-
ing 2% donkey serum for 1 hour at room temperature, then
incubated with goat anti-digoxigenin-DyLight-594 (Vector Labs;
1:1,1000), mouse anti-CD68 (1:400; clone KP1, Dako), mouse
anti-CD163 (1:400; clone 10D6; Novocastra/Leica), and rabbit
monoclonal anti-CD3 (clone SP7; Labvision; 1:200) in TBS-Tw
containing 2% donkey serum overnight at 4uC. Slides were
washed in TBS-Tw, incubated with donkey anti-goat–Alexa594,
donkey anti-mouse–Alexa488, and donkey anti-rabbit–Alexa647
(all Invitrogen; 1:400) for 1 hour at room temperature in the dark
and washed in TBS-Tw. Slides were incubated with 0.1% Sudan
Black B in 70% ethanol (Cat. No. 4410; ENG Scientific) and 16
TBS for 30 minutes at room temperature to quench autofluo-
rescence then incubated with 300 nM DAPI for 10 min. Slides
were washed, mounted with ProlongH Gold (Invitrogen) and
imaged on an Olympus FV10i confocal microscope using a 606
phase contrast oil-immersion objective (NA 1.35) imaging using
sequential mode to separately capture the fluorescence from the
different fluorochromes at an image resolution of 102461024
pixels.
Measurement of relative SIV vRNA abundance within
distinct cell populations
Volumetric confocal images (Z-stack) were taken from lymph
node and jejumal tissues following SIV F-ISH using the
Nyquist sampling method using an Olympus FV10i confocal
microscope with a 606 phase contrast oil-immersion objective
(NA 1.35) with imaging using sequential mode to separately
capture the fluorescence from the different fluorochromes at an
image resolution of 102461024 pixels. Laser settings (gains and
power) were set to ensure no pixel saturation in the SIV vRNA
(Alexa594) channel and kept constant for all sample collections
for each animal imaged. Images were opened in the Olympus
FV10-ASW software (v3.1) and well-defined cellular regions
were manually drawn around SIV vRNA+ macrophages and T
cells from the compressed Z-stack image. The integrated
intensity within these defined cell regions was measured in each
Z-plane. The integrated intensity (or intensity integration) is
the sum of the pixel intensities for a channel of interest within
a specified object, and thus, the sum of the integrated
intensities from each Z-stack is the total of the pixel intensities
within each object volume. Thus, the ‘‘relative abundance’’ of
SIV vRNA within the volume of each cell of interest was
determined by summing the integrated intensities from each
Z-plane.
Plasma levels of sCD163
Soluble CD163 (sCD163) plasma levels were quantified by
ELISA according to manufacturer’s protocol (Trillium Diagnos-
tics) using a 1:50 dilution of plasma samples.
Statistical analysis
Repeated-measures analyses for each outcome (CD4+ T cells;
CD4+Ki-67+ T cells; CD14+CD16+; CD14+CD16+Ki-67+; and
viral load) were performed with a means model with SAS Proc
Mixed (version 9) providing separate estimates of the means by
weeks post-depletion and infection between groups. A com-
pound-symmetric variance-covariance form in repeated mea-
surements was assumed for each outcome and robust estimates
of the standard errors of parameters were used to perform
statistical tests and construct 95% confidence intervals [40]. T-
test or Mann Whitney test were used to compare the differences
between the model-based treatment means (least-squares means)
at each time point within the framework of the mixed effects
linear model. Statistical tests were 2-sided. Pearson product-
moment correlation coefficients were utilized to estimate linear
associations for normally distributed data and Spearman rank
correlation coefficients were used for skewed and other non-
normal distributions. A P value #0.05 was considered statisti-
cally significant for the correlation analyses. The mean 6 SEM
were used as descriptive statistics for each continuous outcome.
The rate of decay of virus was estimated by taking the linear
slope of the natural log-transformed data of viral load from day
0 to 7 of treatment. The half-life is calculated as ln(2)/decay
rate.
Supporting Information
Figure S1 Absolute levels of proliferating and CCR5+
CD4+ T cells are significantly lower in CD4-depleted
SIV-infected RMs than in controls. The absolute numbers of
circulating CD4+ (a), CD4+Ki-67+ (b) or CD4+CCR5+ (c) T cells
in severely depleted (orange square; n = 3), intermediately depleted
(blue diamond; n = 5), and control (black circle; n = 4) RMs are
shown. Total, proliferating, and CCR5+ T cell levels were similar
in intermediately depleted and severely depleted animals, and
significantly lower than those found in controls at all experimental
time points (as assessed by repeated-measures analyses).
(TIFF)
Figure S2 The level of soluble CD163 (sCD163) corre-
lates with viremia in SIV-infected RMs. Shown is the
correlation between plasma levels of sCD163 and viremia
(expressed as SIVmac251Gag RNA copies/mL) in all SIV-infected
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RMs (n= 12) included in the study. Statistical analyses were
determined by Spearman rank correlation tests.
(TIFF)
Figure S3 The number of TUNEL – but not active
caspase 3 – positive cells in the brain is significantly
higher in CD4-depleted SIV-infected RMs than in
controls. The number of cells staining positively for TUNEL
(a) and active Caspase 3 (b) within brain tissue is shown for SIV-
infected controls (closed circle; n = 3), CD4-depleted animals
(orange square; n= 4), and CD4-depleted, ART-treated RMs
(open square; n= 7).
(TIFF)
Table S1 Survival of CD4 depleted SIV-infected RMs.
Antibody-mediated depletion of CD4 T cells prior to SIV
infection results in fast disease progression, with seven out of
eight RMs that required to be euthanized few days after
initiation of ART. The table lists the day post-infection and
post-ART initiation, as well as the CD4 count, at which each
animal was sacrificed. *RVl11 survived throughout the entire
study and was euthanized at day 234 post-infection. This animal
completed 105 days of ART and was sacrificed at day 70 post
ART-interruption.
(DOC)
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